Gastrointestinal Radiology: Page 142

VC antispasmodics show mixed distension results, real patient-acceptance gains
By Eric Barnes
Virtual colonoscopy studies using intravenous antispasmodics continue to garner mixed results regarding their ability to optimize colonic distension. In fact, two European trials recently came to opposing conclusions on distension. One of the studies, however, found that patients overwhelmingly preferred virtual colonoscopy when they received the drugs.
August 26, 2004
2004 08 20 15 26 40 706
Mallinckrodt starts shipping NeutroSpec
By AuntMinnie.com staff writers
Contrast developer Mallinckrodt of St. Louis has started the first U.S. shipments of its NeutroSpec radiopharmaceutical.
August 19, 2004
E-Z-EM completes AngioDynamics spin-off
By AuntMinnie.com staff writers
Contrast agent and virtual colonoscopy developer E-Z-EM of Lake Success, NY, has completed the spin-off of its AngioDynamics subsidiary, declaring a special stock dividend of 9.2 million shares of common stock.
August 19, 2004
Bard to unload endoscopic assets
By AuntMinnie.com staff writers
Interventional technology provider C.R. Bard has signed an agreement to sell some of the assets of its endoscopic technologies division to medical technology firm ConMed for $80 million.
August 17, 2004
What virtual colonoscopy misses might not matter
By Eric Barnes
Does virtual colonoscopy miss dangerous polyps? Not necessarily, say researchers from NYU Medical Center in New York City. Their study suggested that VC combined with with the appropriate screening interval can catch most adenomas before they progress to malignancy.
August 17, 2004
Siemens adds 4D to Antares
By AuntMinnie.com staff writers
Siemens Medical Solutions has begun shipping its fourSight 4D ultrasound imaging technology with its Sonoline Antares ultrasound scanners.
August 15, 2004
E-Z-EM debuts VoLumen
By AuntMinnie.com staff writers
E-Z-EM has introduced VoLumen, a low-density barium sulfate suspension used as an oral contrast in multidetector CT (MDCT) and PET/CT studies. VoLumen is designed to overcome the limitations of water and higher-density positive oral contrasts currently used in these studies, according to the Lake Success, NY-based vendor.
August 9, 2004
Vital Images and E-Z-EM renew alliance
By AuntMinnie.com staff writers
Vital Images of Plymouth, MN, and E-Z-EM of Lake Success, NY, have renewed their alliance covering the sale of virtual colonoscopy software.
August 2, 2004
Ultralow-dose VC appears feasible
By Eric Barnes
Researchers from the Academic Medical Center in Amsterdam have reported that very-low-dose virtual colonoscopy -- as low as 1.4 effective mAs rather than 60 or 80 -- may be a feasible alternative to the standard or even low-dose VC exam.
August 2, 2004
E-Z-EM reports record 2004
By AuntMinnie.com staff writers
Contrast agent and virtual colonoscopy developer E-Z-EM reported record fiscal fourth-quarter net sales of $41.6 million, up 13% compared with the $36.9 million booked in the fourth quarter of 2003 (end-May 31).
July 29, 2004
Standard-dose no better than low-dose CT for diagnosing appendicitis
By Eric Barnes
There is no significant difference in the accuracy of low-dose versus normal-dose CT for diagnosing acute appendicitis, according to researchers from Erasmus Hospital in Brussels, Belgium.
July 27, 2004
Digital subtraction enhances colonic lesions in MRC
By Eric Barnes
A new digital subtraction technique improves lesion conspicuity in MR colonography, researchers from the University of Essen in Germany reported in a preliminary study. By subtracting the plain from the contrast-enhanced MR colonography data, they hope to improve their ability to detect colorectal polyps and cancer.
July 20, 2004
2004 07 20 15 51 59 706
Previous Page
Page 142 of 170
Next Page